Loading clinical trials...

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies | Clinical Trials | Clareo Health

COMPLETED

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

NCT07193290•Kenvue Brands LLC

View on ClinicalTrials.gov

Summary

This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main study endpoints across balanced attributes of study sub-populations.

Eligibility

Age

18 - 65 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Self-reported Monk skin type 1 to 10, targeting to complete at least 100 subjects for each Monk skin type.
•18 to 65 years old, targeting to complete:
•* 18- to 40-year-old age range: at least 50 subjects within each Monk type
•* 41- to 65-year-old age range: at least 50 subjects within each Monk type
•Lives within an Inner City, Urban, Suburban, or Rural community type (as determined by self-report or provided zip code), targeting to complete:
•* Inner City/Urban community type: at least 25 subjects within each age range and Monk type
•* Suburban/Rural community type: at least 25 subjects within each age range and Monk type
•Has electronically accepted the Consent for Photograph Release and ICD including Health Insurance Portability and Accountability Act (HIPAA) disclosure.
•Has a personal smartphone with a camera and an internet connection (wi-fi, cellular services, etc.).
•Intends to complete the study and willing and able to follow all study instructions.

Exclusion Criteria

•Has known allergies or adverse reactions to topical adhesives.
•Is simultaneously participating in any other clinical study for the duration of this study or has participated in any product-use study within 30 days prior to remote Visit 1.
•Is an employee/contractor or immediate family member of the PI, study technology provider, laboratory, or Sponsor.

Locations (1)

Laina Enterprises, Inc.

Apopka, Florida, United States

Key Dates

Start Date

May 13, 2025

Primary Completion Date

October 1, 2025

Completion Date

October 1, 2025

Last Updated

December 19, 2025

Enrollment

1,027

ACTUAL participants

Conditions

Skin AgingHair CareSkin Microbiome

Interventions

Lifestyle Questionnaire

OTHER

Self-portrait image (Face and Hair)

OTHER

Skin microbiome collection

DIAGNOSTIC_TEST

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

NCT07261748

Aesthetic ProceduresCosmetic Techniques+2 more

View study

ACTIVE_NOT_RECRUITING

Skin Microbiome of Chinese Population Cohort Study

NCT05804851

Skin Microbiome

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

Inclusion Criteria

Exclusion Criteria

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

Skin Microbiome of Chinese Population Cohort Study

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

Efficacy and Safety of NP-2007 on Skin Health

Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.

A Clinical Study Testing How Well the Medical Device HTIC (a Type of Animal-derived Collagen) Works in Treating Skin Problems, Such as Scars, Loss of Firmness, and Volume in Certain Areas of the Face and Body